In this article, we will discuss Durvalumab (Warnings-6). So, let’s get started.
Immune-Mediated Pneumonitis
Durvalumab can cause immune-mediated pneumonitis. The incidence of pneumonitis is higher in patients
who have received prior thoracic radiation.